Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Skin Neoplasms 2Melanoma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Turcot syndrome 1Solid Tumors 1Solid Tumor, Adult 1Rectal Neoplasms 1Radiation Pneumonitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1NSCLC 1Motor Activity 1Lung Neoplasms 1Locally Advanced Esophageal Squamous Cell Carcinoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

Gemcitabine 18pembrolizumab 16Cisplatin 16Nivolumab 15atezolizumab 11durvalumab 9Specimen Handling 9Magnetic Resonance Spectroscopy 9Cystectomy 8Carboplatin 7Ipilimumab 6Fluorouracil 6avelumab 5Mitomycin 5sacituzumab govitecan 4erdafitinib 4enfortumab vedotin 4Surgical Procedures, Operative 4Immunoglobulin G 4Disulfides 4Biopsy 4tremelimumab 3cabozantinib 3Transurethral Resection of Bladder 3Surveys and Questionnaires 3Radiation 3Platinum 3Paclitaxel 3Leucovorin 3Docetaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Urinary Bladder Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT05241340 2025-10-24

RAD-VACCINE

The Methodist Hospital Research Institute

Phase 2 Active not recruiting
33 enrolled
Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡